Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Imatinib in combination with cytarabine as compared to imatinib alone in patients with first chronic phase chronic myeloid leukemia. A prospective randomised phase III study.

Trial Profile

Imatinib in combination with cytarabine as compared to imatinib alone in patients with first chronic phase chronic myeloid leukemia. A prospective randomised phase III study.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Aug 2014

At a glance

  • Drugs Cytarabine; Imatinib
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Acronyms HOVON-78-CML
  • Most Recent Events

    • 16 Aug 2014 New source identified and integrated (European Clinical Trials Database record:EudraCT2005-003839-41)
    • 01 Oct 2013 According to the European Clinical Trials database record, trial status is completed.
    • 01 Aug 2013 Results published in the Annals of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top